Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC).

MLA

Pretorius, Etheresia, et al. “Prevalence of Symptoms, Comorbidities, Fibrin Amyloid Microclots and Platelet Pathology in Individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC).” Cardiovascular Diabetology, vol. 21, no. 1, Aug. 2022, p. 148. EBSCOhost, https://doi.org/10.1186/s12933-022-01579-5.

APA

Pretorius, E., Venter, C., Laubscher, G. J., Kotze, M. J., Oladejo, S. O., Watson, L. R., Rajaratnam, K., Watson, B. W., & Kell, D. B. (2022). Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC). Cardiovascular Diabetology, 21(1), 148. https://doi.org/10.1186/s12933-022-01579-5

Chicago

Pretorius, Etheresia, Chantelle Venter, Gert Jacobus Laubscher, Maritha J Kotze, Sunday O Oladejo, Liam R Watson, Kanshu Rajaratnam, Bruce W Watson, and Douglas B Kell. 2022. “Prevalence of Symptoms, Comorbidities, Fibrin Amyloid Microclots and Platelet Pathology in Individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC).” Cardiovascular Diabetology 21 (1): 148. doi:10.1186/s12933-022-01579-5.